| # | Drug | Count |
|---|---|---|
| 0 | DOCETAXEL | 6 |
| 1 | DOCETAXEL ANHYDROUS | 6 |
| 2 | CYCLOPHOSPHAMIDE | 5 |
| 3 | CYCLOPHOSPHAMIDE FOR INJECTION | 5 |
| 4 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 5 |
| 5 | BEVACIZUMAB | 4 |
| 6 | AFLIBERCEPT | 2 |
| 7 | DUTASTERIDE | 2 |
| 8 | ERGOCALCIFEROL | 2 |
| 9 | VITAMIN C | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | VORETIGENE NEPARVOVEC-RZYL | 1 | 0.0066 |
| 1 | COCAINE HYDROCHLORIDE | 1 | 0.0026 |
| 2 | CHROMIC CHLORIDE | 1 | 0.0012 |
| 3 | DUTASTERIDE | 2 | 0.0002 |
| 4 | OZANIMOD HYDROCHLORIDE | 1 | 0.0001 |
| 5 | DOCETAXEL ANHYDROUS | 6 | 0.0001 |
| 6 | DOCETAXEL | 6 | 0.0001 |
| 7 | ERGOCALCIFEROL | 2 | 0.0001 |
| 8 | AFLIBERCEPT | 2 | 0.0001 |
| 9 | MOXIFLOXACIN HYDROCHLORIDE | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Provitamin D2 Compound [EPC] | 2 | 0.0001 |
| 1 | Microtubule Inhibitor [EPC] | 6 | 0.0000 |
| 2 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 6 | 0.0000 |
| 3 | CTLA-4-directed Blocking Antibody [EPC] | 1 | 0.0000 |
| 4 | Alkylating Drug [EPC] | 5 | 0.0000 |
| 5 | 5-alpha Reductase Inhibitor [EPC] | 2 | 0.0000 |
| 6 | Arteriolar Vasodilator [EPC] | 1 | 0.0000 |
| 7 | Vitamin C [EPC] | 2 | 0.0000 |
| 8 | CD20-directed Cytolytic Antibody [EPC] | 1 | 0.0000 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 1 | 0.0000 |